NPC
IBB icon

National Planning Corporation’s iShares Biotechnology ETF IBB Stock Holding History

National Planning Corporation’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,669
Closed -$742K – 288
2017
Q3 		$742K Sell
6,669
-9,507
-59% -$1.02M 0.06% 284
2017
Q2 		$1.68M Sell
16,176
-27,141
-63% -$2.67M 0.13% 176
2017
Q1 		$4.21M Buy
43,317
+1,098
+3% +$105K 0.32% 67
2016
Q4 		$3.94M Buy
42,219
+9,438
+29% +$859K 0.31% 69
2016
Q3 		$2.85M Buy
32,781
+13,338
+69% +$1.27M 0.23% 94
2016
Q2 		$1.91M Buy
19,443
+7,485
+63% +$672K 0.15% 146
2016
Q1 		$1.02M Sell
11,958
-21,990
-65% -$1.97M 0.09% 225
2015
Q4 		$2.9M Sell
33,948
-19,659
-37% -$2.13M 0.24% 98
2015
Q3 		$6.03M Buy
53,607
+7,176
+15% +$861K 0.55% 34
2015
Q2 		$5.68M Buy
46,431
+35,364
+320% +$4.23M 0.51% 40
2015
Q1 		$1.25M Sell
11,067
-6,990
-39% -$771K 0.11% 178
2014
Q4 		$1.88M Buy
18,057
+5,106
+39% +$496K 0.13% 147
2014
Q3 		$1.19M Buy
12,951
+75
+0.6% +$6.58K 0.09% 218
2014
Q2 		$1.1M Sell
12,876
-1,548
-11% -$122K 0.09% 229
2014
Q1 		$1.16M Buy
14,424
+480
+3% +$40K 0.1% 207
2013
Q4 		$1.05M Buy
13,944
+393
+3% +$27.9K 0.09% 221
2013
Q3 		$966K Buy
13,551
+6,141
+83% +$402K 0.09% 219
2013
Q2 		$428K Buy
+7,410
New +$428K 0.05% 312

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

National Planning Corporation's IBB Position: Q4 2017 in Review

National Planning Corporation sold out of iShares Biotechnology ETF (IBB) in Q4 2017, closing a stake of 6,669 shares — an estimated $742K sold.

National Planning Corporation first reported a position in IBB in Q2 2013 and held it in 18 quarters. The position peaked at $6.03M in Q3 2015. 624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.

  • National Planning Corporation reported no remaining iShares Biotechnology ETF position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 6,669 iShares Biotechnology ETF shares in Q4 2017, an estimated $742K.
  • National Planning Corporation first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 18 quarters.
  • National Planning Corporation's iShares Biotechnology ETF position peaked at $6.03M in Q3 2015.
  • 624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.